Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gasperini

Showing results (521-530 of 981) with videos related to

Pageof 99
Sort By:
Journal of Neurology|August 10, 2025
The use of high-efficacy disease-modifying therapies in multiple sclerosis: recommendations from an expert Delphi consensusMassimo Filippi, Maria Pia Amato, Diego Centonze, et al.
Molecular Neurobiology|November 10, 2016
Serum Compounds of Energy Metabolism Impairment Are Related to Disability, Disease Course and Neuroimaging in Multiple SclerosisGiacomo Lazzarino, Angela M Amorini, Axel Petzold, et al.
Frontiers in Psychiatry|March 20, 2023
The other side of COVID-19: A cross-sectional study on mental health in a sample of Italian nurses during the second waveErika Renzi, Valentin Imeshtari, Dima Masud, et al.
Journal of Infection and Public Health|October 22, 2023
Epidemiology of listeriosis in a region in central Italy from 2010 to 2019: Estimating the real incidence and space-time analysis for detecting cluster of casesElisa Ponzio, Katiuscia Di Biagio, Jacopo Dolcini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 25, 2017
Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosisCarla Tortorella, Vita Direnzo, Maddalena Ruggieri, et al.
Retina (Philadelphia, Pa.)|September 9, 2011
Structural and functional implications of severe foveal dystopia in epiretinal membranesDanielle Lo, Florian Heussen, Hoai-Ky Ho, et al.
Journal of Neurology|May 24, 2022
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinionMassimo Filippi, Maria Pia Amato, Diego Centonze, et al.
Annals of Clinical and Translational Neurology|February 3, 2021
Dynamics of pseudo-atrophy in RRMS reveals predominant gray matter compartmentalizationNicola De Stefano, Antonio Giorgio, Giordano Gentile, et al.
Cells|June 7, 2019
Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis PatientsAlessia Capone, Manuela Bianco, Gabriella Ruocco, et al.
Genes|February 25, 2023
Treatment Dilemma in Children with Late-Onset Pompe DiseaseMartha Caterina Faraguna, Viola Crescitelli, Anna Fornari, et al.
Pageof 99

Showing results (521-530 of 981) with videos related to

Sort By:
Pageof 99
Journal of Neurology|August 10, 2025
The use of high-efficacy disease-modifying therapies in multiple sclerosis: recommendations from an expert Delphi consensusMassimo Filippi, Maria Pia Amato, Diego Centonze, et al.
Molecular Neurobiology|November 10, 2016
Serum Compounds of Energy Metabolism Impairment Are Related to Disability, Disease Course and Neuroimaging in Multiple SclerosisGiacomo Lazzarino, Angela M Amorini, Axel Petzold, et al.
Frontiers in Psychiatry|March 20, 2023
The other side of COVID-19: A cross-sectional study on mental health in a sample of Italian nurses during the second waveErika Renzi, Valentin Imeshtari, Dima Masud, et al.
Journal of Infection and Public Health|October 22, 2023
Epidemiology of listeriosis in a region in central Italy from 2010 to 2019: Estimating the real incidence and space-time analysis for detecting cluster of casesElisa Ponzio, Katiuscia Di Biagio, Jacopo Dolcini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 25, 2017
Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosisCarla Tortorella, Vita Direnzo, Maddalena Ruggieri, et al.
Retina (Philadelphia, Pa.)|September 9, 2011
Structural and functional implications of severe foveal dystopia in epiretinal membranesDanielle Lo, Florian Heussen, Hoai-Ky Ho, et al.
Journal of Neurology|May 24, 2022
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinionMassimo Filippi, Maria Pia Amato, Diego Centonze, et al.
Annals of Clinical and Translational Neurology|February 3, 2021
Dynamics of pseudo-atrophy in RRMS reveals predominant gray matter compartmentalizationNicola De Stefano, Antonio Giorgio, Giordano Gentile, et al.
Cells|June 7, 2019
Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis PatientsAlessia Capone, Manuela Bianco, Gabriella Ruocco, et al.
Genes|February 25, 2023
Treatment Dilemma in Children with Late-Onset Pompe DiseaseMartha Caterina Faraguna, Viola Crescitelli, Anna Fornari, et al.
Pageof 99